HSBC Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $465K | Sell |
|
|||||
|
2025
Q2 | $656K | Sell |
|
|||||
|
2025
Q1 | $677K | Buy |
|
|||||
|
2024
Q4 | $677K | Buy |
|
|||||
|
2024
Q3 | $529K | Sell |
|
|||||
|
2024
Q2 | $759K | Buy |
|
|||||
|
2024
Q1 | $479K | Buy |
|
|||||
|
2023
Q4 | $127K | Buy |
|
|||||
|
2023
Q3 | $134K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $246K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $260K | Sell |
|
|||||
|
2020
Q3 | $164K | Sell |
|
|||||
|
2020
Q2 | $628K | Sell |
|
|||||
|
2020
Q1 | $382K | Buy |
|
|||||
|
2019
Q4 | $38K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $80K | Buy |
|